Cancer Patients With Diabetes May Have Worse Outcomes on ICIs
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
Cancer patients with type 2 diabetes may have worse survival outcomes on immune checkpoint inhibitor therapy, a new study suggests.
The sBLA is supported by data from the phase 3 CheckMate -76K trial which included 790 patients after complete resection of stage IIB or IIC melanoma.
Occupational case-control studies addressing melanoma risk in career firefighters are reviewed.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Roughly half of hospitals accredited by the ACS-CoC failed to disclose the cost of 5 common cancer surgeries, researchers found.
Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.
Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.